Human papillomavirus (HPV) vaccineCervical cancer preventionAwareness and willingnessChina only recently introduced HPV vaccines, and HPV vaccination is yet to be included in the National Immunization Plan. This article offers an overview of current experience in HPV vaccination in China, including the ...
Nurses inject human papilloma virus (HPV) 9-valent vaccine for Shi Jiayu from Beijing at Boao Super Hospital United Family Boao Clinic in Boao, south China's Hainan Province, May 30, 2018. The first batch of HPV 9-valent vaccines in Chinese mainland are put into injection on Wednesday. (...
China is also developing its own HPV vaccine, and it is expected to enter the market in 2022. Gardasil was developed by Chinese cancer researcher Zhou Jian and Australian immunologist Ian Frazer. In 1995, Zhou and Frazer started cooperating with Merck and Co to develop the vaccine. After Zhou...
The World Health Organization recently approved a Chinese HPV vaccine, and some regions in the country have begun providing it for free. Professor Hu Naijun from the School of Public Policy and Management at the University of the Chinese Academy of Sciences shares with us his ...
these studies did not include participants from mainland China, which has a substantial burden of HPV-related disease. This is the first safety report with a follow-up period of up to 90 months from a randomized, double-blind, place...
Merck Sharp & Dohme’s quadrivalent human papillomavirus (HPV) vaccine has become the first jab against the virus approved for use on men in China, the U.S. pharmaceutical giant said Wednesday. The China National Medi...
For most Chinese, the HPV vaccine is still a relatively new concept, having only been made available to the general public in 2016. Despite the vaccine’s increased prominence, there is still a lack of investigation about how the public is influencing the conversation about HPV vaccines and ...
The country will summarize the experience and further promote the free HPV vaccination policy to cover more people, as well as strengthen coordination among different departments to enlarge vaccine supply, said Wang. The two-valent, four-valent, and nine-valent HPV vaccines available in China are ...
Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese girls and women aged 9 to 45 years. Hum Vaccin Immunother. 2014;10(7):1795-1806. doi:10.4161/hv.28702 Li R, Li Y, Radley D, et al. Safety and immunogenicity of a vaccine targeting human ...
The first girl to be inoculated with China-produced 2-valent HPV vaccine in Wuhan, central China's Hubei Province, May 18, 2020. /CFP China will expand the coverage of free human papillomavirus (HPV) vaccinations, and step up efforts to curtail the shortage of the vaccine...